The Viral Diagnostic Test Kits Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for viral diagnostic test kits has experienced robust growth recently. The market size is projected to expand from $16.26 billion in 2024 to $17.62 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.4%.
The Viral Diagnostic Test Kits market is forecasted to reach a size of $23.99 billion in 2029, with an anticipated compound annual growth rate (CAGR) of 8.0%.
Download Your Free Sample of the 2025 Viral Diagnostic Test Kits Market Report and Uncover Key Trends Now!The drivers in the viral diagnostic test kits market are:
• A surge in healthcare expenditure
• The acceleration of global travel
• Rising prevalence of chronic viral infections
• Increased demand for home testing kits and the growth of personalized medicine
The viral diagnostic test kits market covered in this report is segmented –
1) By Test: Traditional Tests, Rapid Test
2) By Test Type: Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types
3) By End-User: Research Laboratories, Clinics, Hospitals, Other End Users
The trends in the viral diagnostic test kits market are:
• The market is expected to be heavily influenced by technological advancements.
• Point-of-care testing is representing a significant future trend.
• The use of AI and data analytics is emerging as a noteworthy trend.
• Integration with digital health records and next-generation sequencing will shape the market moving forward.
The major players in the viral diagnostic test kits market are:
• F. Hoffmann-La Roche AG
North America was the largest region in the viral diagnostic test kits market in 2024